Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Craniodigital syndrome - intellectual deficit is characterized by syndactyly of the fingers and toes, characteristic facies (`startled' facial expression with a small pointed nose, micrognathia, long dark eyelashes and prominent eyebrows) and intellectual deficit.
Features include very common findings: Brachycephaly, Micrognathia, Narrow nasal bridge, and Long eyelashes and others; and sometimes findings: Spina bifida occulta.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 1 | Intellectual disability |
Biomarker and diagnostic research for craniodigital syndrome-intellectual disability syndrome has been reported in the published literature.
Phenotype severity distribution: 13 very common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for craniodigital syndrome-intellectual disability syndrome.
143 publications have been identified in PubMed for craniodigital syndrome-intellectual disability syndrome. Research spans Review / Meta-Analysis (66%), Basic Science / Preclinical (13%), and Epidemiology / Natural History (10%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 94 | 66% |
Data assembled from 5 of 12 sources · Last updated Sep 20, 2026, 2:37 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
1 |
Short stature |
Arms and legs | 1 | Finger syndactyly |
Skin | 1 | Abnormal dermatoglyphics |
Laboratory research |
19 |
13% |
Disease patterns and progression | 14 | 10% |
Patient case studies | 9 | 6% |
Testing and diagnosis research | 3 | 2% |
Other research | 2 | 1% |
Clinical study results | 2 | 1% |
Gąsiorowska J (2026). [PMID: 42023627](https://pubmed.ncbi.nlm.nih.gov/42023627/). *Pediatr Endocrinol Diabetes Metab*. [Review / Meta-Analysis]
Amado C (2026). [PMID: 40975490](https://pubmed.ncbi.nlm.nih.gov/40975490/). *Ann Allergy Asthma Immunol*. [Review / Meta-Analysis]
Ferri C (2026). [PMID: 41798958](https://pubmed.ncbi.nlm.nih.gov/41798958/). *Front Immunol*. [Review / Meta-Analysis]
Anderson EN (2026). [PMID: 41468891](https://pubmed.ncbi.nlm.nih.gov/41468891/). *Am J Hum Genet*. [Basic Science / Preclinical]
Papazachariou A (2026). [PMID: 41128447](https://pubmed.ncbi.nlm.nih.gov/41128447/). *Curr Opin Clin Nutr Metab Care*. [Review / Meta-Analysis]
Lee S (2026). [PMID: 41206258](https://pubmed.ncbi.nlm.nih.gov/41206258/). *Am J Geriatr Psychiatry*. [Review / Meta-Analysis]
Paller AS (2025). [PMID: 40184496](https://pubmed.ncbi.nlm.nih.gov/40184496/). *Br J Dermatol*. [Review / Meta-Analysis]
Fann Marko R (2025). [PMID: 39987477](https://pubmed.ncbi.nlm.nih.gov/39987477/). *Harefuah*. [Review / Meta-Analysis]
Van't Hoff C (2025). [PMID: 41308001](https://pubmed.ncbi.nlm.nih.gov/41308001/). *J Frailty Aging*. [Review / Meta-Analysis]
Gobble MRS (2025). [PMID: 40128490](https://pubmed.ncbi.nlm.nih.gov/40128490/). *Curr Diab Rep*. [Review / Meta-Analysis]